Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 260 results for "zydus group"

Zydus receives USFDA approval for Voriconazole Tablets
India Infoline

Zydus Cadila gets USFDA's final nod for fungal treatment drug

The drug will be produced at the groups formulations manufacturing facility at Baddi (Himachal Pradesh). Citing IMS data, the company said the estimated sales for Voriconazole tablets is USD 92.8 million as on March 2016. The Ahmedabad-based group now has ... Business Standard, 1 day ago
Zydus gets FDA nod to market anti-fungal drug Smart Investor, 1 day ago
Zydus gets final USFDA nod to sell Voriconazole Tab Hindu Business Line, 1 day ago
[x]  

1 images for "zydus group"

Financial Express, 2 weeks ago

Zydus to present Lipaglyn clinical data at AACE annual meeting

The Zydus Group, a leading global healthcare provider, announced that new clinical data on Lipaglyn (Saroglitazar) will be presented at the American Association of Clinical Endocrinologists (AACE) 25th Annual Scientific and Clinical Congress to be ...
 PharmaBiz2 days ago Two presentations highlighting Zydus drug Lipaglyn will be featured at the AACE Annual meeting  Pharma Focus Asia2 days ago
India Infoline

Cadila Q4 net up 11% to Rs 389 cr; to raise up to Rs 18,500 cr

New Delhi, May 13 () Zydus Cadila group firm Cadila Healthcare today reported a 10.93 per cent rise in net profit to Rs 388.7 crore for the March quarter and also received nod from its board to raise up to Rs 18,500 crore through issuance of shares ...
 Times of India1 week ago Cadila profit at Rs 389 cr; to raise up to Rs 18,500 cr  The Freepress Journal1 week ago Zydus Wellness Q4 net profit at Rs.25.8 crore  India Infoline2 weeks ago Cadila Q4 net up 11% to Rs 389 crore; to raise up to Rs 18,500 crore  Economic Times1 week ago
[x]  
Pharma Letter

Zydus Group buys Actibile from Albert David

Healthcare player, Zydus Group on Monday announced acquisition of Actibile from Albert David Limited through its flagship company, Cadila Healthcare Limited. The company has entered into a definitive agreement to acquire the gastroenterology segment, which is ...
 Business Line1 month ago Cadila Healthcare slips 1% despite FDA nod to Zydus  India Infoline1 month ago Zydus gets rights to gastro drug Actibile  Pharma Letter1 month ago Zydus buys gastro therapy brand, Actibile from Albert David  PharmaBiz1 month ago
[x]  
Business Standard

Zydus acquires gastro drug 'Actibile' from Kolkata-based Albert David

Ahmedabad-based pharma major Cadila Healthcare has acquired Actibile, a gastroenterology brand from Kothari Group company Albert David for an undisclosed sum. The deal will be financed through internal accruals.The company today said in a statement ...
 Smart Investor1 month ago Zydus Cadila buys gastrointestinal brand from Albert David  VC Circle1 month ago Zydus Health Acquires Gastrointestinal Drug From Albert David  NDTV1 month ago Zydus Health acquires gastro drug 'Actibile' from Albert David  Economic Times1 month ago
India Infoline

High jump! Alber David surges 6% on Zydus deal

Shares of Albert David Ltd, a mid-cap pharmaceutical company, are currently trading 5.69% higher at Rs. 310 after the company yesterday enter into a deal with Zydus Cadila to sell one of its brands Actibile. Since the yesterday's announcement, ...
 India Infoline1 month ago Albert David ends 7% higher on Rs. 55 cr deal with Zydus Cadila  India Infoline1 month ago Upsurge! Alber David ends 7% higher on Zydus deal  India Infoline1 month ago

155 firms to pay Rs 12000 crore dividend before March 31

Indian promoter groups' share is Rs 5,930 crore. The post-budget rush by companies to declare dividends and pay it to all shareholders before March 31 will result in total dividend payouts of about Rs 11,980 crore by about 155 firms, of which about Rs 5,930 ...
 Asian Age2 months ago 155 firms to pay Rs 12k cr dividend before March 31  The Financial Chronicle2 months ago

Global Non-Sugar Sweeteners Market Professional Survey Report 2016

QYResearch Group This report Mainly covers the following product types The segment applications including Segment regions including (the separated region report can also be offered) USA China Europe South America Japan Africa ...
 MarketResearch.com1 month ago Global Measles Report 2016 - Pipeline Review of 10 Companies & Drug Profiles - Research and Markets  4 Traders13 hours ago Global Varicella Zoster (HHV-3) Infections Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Astellas Pharma, Merck, TSRL - Research and Markets  Minyanville2 weeks ago Varicella Zoster (HHV-3) Infections 2016 Market Therapeutics H1 Pipeline Research Review  Before It's News1 week ago
[x]  

Merck Group starts phase III trial fo...

The global clinical trial will be carried out in 406 patients and is designed to compare the safety, efficacy and immunogenicity of MSB11022 versus blockbuster arthritis and psoriasis drug Humira in patients with moderate to severe chronic plaque ...
 GaBi Online2 months ago

DPP IV Inhibitors

/PRNewswire/ -- This report analyzes the worldwide markets for in US$ Million. The Global market is analyzed by the following Drugs: Sitagliptin, Vildagliptin, Saxagliptin, and Other DPP-IV Inhibitors. The US market is analysed in terms of sales and ...
 Biotechgate1 hour ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less